Psychedelics vs. inflammation
One thing you probably don’t think of… [psychedelics] as is an anti-inflammatory medicine. Like aspirin or ibuprofen … It turns out, there may be reason to.
The data is unequivocal if you’re a mouse, because the studies have already been conducted. And Dr. Charles Nichols is working on extending this research into humans. But given that over 50-60% of people will suffer chronic inflammation as a disease mechanism at some point in their life, a potential therapy is extremely valuable. And — better late than never — science is now actively seeking answers in this new area, with funding coming in from the National Institutes of Health (NIH) as well as private disease foundations … Researchers into psychedelics have frequently been hampered by the War on Drugs, a cultural wet blanket with influence that extends to the IRBs (Institutional Review Boards) that approve or disapprove the proposals made by would-be scientific investigators … Dr. Nichols seems to be side-stepping psychedelics’ negative stigma quite effectively, though (something his father, Dr. David Nichols has done also). In part, this is because studies into the anti-inflammatory potential of psychedelics has nothing to do with their “metaphysical” or psychological aspects. Inflammation, it seems, can be fought at dose ranges so low that no psychedelic effects can be noticed.
From the Article (smartdrugsmarts):
Psychedelics vs. inflammation with Dr. Charles Nichols
Artwork Fair Use: WelcomeImages